315 related articles for article (PubMed ID: 34599996)
1. The roles of lipids in SARS-CoV-2 viral replication and the host immune response.
Theken KN; Tang SY; Sengupta S; FitzGerald GA
J Lipid Res; 2021; 62():100129. PubMed ID: 34599996
[TBL] [Abstract][Full Text] [Related]
2. Lipid-based therapies against SARS-CoV-2 infection.
Alketbi EH; Hamdy R; El-Kabalawy A; Juric V; Pignitter M; A Mosa K; Almehdi AM; El-Keblawy AA; Soliman SSM
Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546604
[TBL] [Abstract][Full Text] [Related]
3. Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease.
Prakash H; Upadhyay D; Bandapalli OR; Jain A; Kleuser B
Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106504. PubMed ID: 33147503
[TBL] [Abstract][Full Text] [Related]
4. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry.
Palacios-Rápalo SN; De Jesús-González LA; Cordero-Rivera CD; Farfan-Morales CN; Osuna-Ramos JF; Martínez-Mier G; Quistián-Galván J; Muñoz-Pérez A; Bernal-Dolores V; Del Ángel RM; Reyes-Ruiz JM
Front Immunol; 2021; 12():796855. PubMed ID: 34975904
[TBL] [Abstract][Full Text] [Related]
6. Host proviral and antiviral factors for SARS-CoV-2.
Lv L; Zhang L
Virus Genes; 2021 Dec; 57(6):475-488. PubMed ID: 34510331
[TBL] [Abstract][Full Text] [Related]
7. The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses.
Roingeard P; Eymieux S; Burlaud-Gaillard J; Hourioux C; Patient R; Blanchard E
Cell Mol Life Sci; 2022 Jul; 79(8):425. PubMed ID: 35841484
[TBL] [Abstract][Full Text] [Related]
8. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
9. Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
Artman C; Brumfield KD; Khanna S; Goepp J
PLoS One; 2021; 16(5):e0252399. PubMed ID: 34048457
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
[TBL] [Abstract][Full Text] [Related]
11. The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses.
Saud Z; Tyrrell VJ; Zaragkoulias A; Protty MB; Statkute E; Rubina A; Bentley K; White DA; Rodrigues PDS; Murphy RC; Köfeler H; Griffiths WJ; Alvarez-Jarreta J; Brown RW; Newcombe RG; Heyman J; Pritchard M; Mcleod RW; Arya A; Lynch CA; Owens D; Jenkins PV; Buurma NJ; O'Donnell VB; Thomas DW; Stanton RJ
J Lipid Res; 2022 Jun; 63(6):100208. PubMed ID: 35436499
[TBL] [Abstract][Full Text] [Related]
12. A lipidomic view of SARS-CoV-2.
Ebrahimi KH; McCullagh JSO
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34313294
[TBL] [Abstract][Full Text] [Related]
13. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
Chen P; Wu M; He Y; Jiang B; He ML
Signal Transduct Target Ther; 2023 Jun; 8(1):237. PubMed ID: 37286535
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.
Ricciotti E; Laudanski K; FitzGerald GA
Adv Biol Regul; 2021 Aug; 81():100818. PubMed ID: 34303107
[TBL] [Abstract][Full Text] [Related]
15. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
16. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
17. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.
Abu-Farha M; Thanaraj TA; Qaddoumi MG; Hashem A; Abubaker J; Al-Mulla F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429572
[TBL] [Abstract][Full Text] [Related]
18. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
19. Ceramide and Related Molecules in Viral Infections.
Beckmann N; Becker KA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073578
[TBL] [Abstract][Full Text] [Related]
20. The constellation of cholesterol-dependent processes associated with SARS-CoV-2 infection.
Barrantes FJ
Prog Lipid Res; 2022 Jul; 87():101166. PubMed ID: 35513161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
